Home

Retail Starter Pack

Technology Transfer Info

Company Information

Privacy Policy

Mueller Medical Product Pipeline

 

Mueller Medical Intl LLC  Product Pipeline in North America

  

The Product Development Program of Mueller Medical is tabulated below.

 

   VETERINARY PRODUCT PIPELINE IN NORTH AMERICA  (Supplement-Based SOS-Enhanced)

 

PRODUCT

INDICATION

Pre-Clinical/Phase I

Phase II/III

Pre-Market

In Market

 

Rx Suppl

Equine Gastrafate

Erosions, Colitic Diarrhea, Colic

xx

xx

xx

xx

Rx Suppl

Dog-Cat Gastrafate

Gastritis, Vomiting, Diarrhea

xx

xx

xx

xx

  

Rx Device

Equine Dermafate

Epidermal Wounds

xx

 

 

 

Rx Device

Dog-Cat Dermafate

Epidermal Wounds

xx

 

 

 

 

OTC

4 Types

Equine Gastralox

Trainers/Owners
Foal/ Train&Show

Low Grade Colic, Poor Appetite

xx

xx

xx

xx

OTC Suppl

Canine Gastralox

Vomiting Diarrhea

xx

xx

xx

xx

OTC Suppl

Feline Gastralox

Vomiting Diarrhea

xx

xx

xx

xx

OTC Suppl

Cainine ColoGastro

Vomiting Diarrhe

xx

xx

xx

xx

OTC Suppl

Feline ColoGastro

Vomiting Diarrheaa

xx

xx

xx

xx

 

HUMAN PRODUCT PIPELINE IN THE NORTH AMERICA

 

PRODUCT

INDICATION

Pre-Clinical/Phase I

Phase II/III

Pre-Market/NDA

n Market

Rx Drug

GastrafateRx   

Functional Dyspepsia

xx

xx

 

 

Rx Drug

GastrafateIB 

IBS, All 3 Forms

xx

xx

 

 

Rx Drug

GastrafateLoAl

GERD

xx

 

 

 

  

Rx Device

OraEsophate

Pediatric/Adult Mucosal Lesions

xx

xx

xx Pre Market Notification

xx Mid-Late 2007

Rx Device

Dermafate Wound

Pediatric/Adult Epidermal Wounds

xx

xx

xx Pre Market Notification

xx Mid-Late 2007

Rx Device

Dermafate Burn

Pediatric/Adult Epidermal Burns

XX

xx

xx Pre Market Notification

xx Mid-Late 2007

  

OTC Suppl

ColoGastro

Upset Stomach-Diarrhea-Heartburn

xx

xx

xx

xx 2006

OTC Suppl

Caralox

Heartburn

xx

xx

xx

xx 2004

OTC Suppl

Caralox Phyto

Heartburn, Severe

xx

xx

xx

xx 2004

OTC Suppl

IBS/Regulan

Irritable Bowel Irregularity

xx

xx

xx

xx 2005

OTC Suppl

TriFiberlan

Fiber Irregularity

xx

xx

xx

xx 2006

 

PRODUCT PIPELINE FOR HUMAN APPLICATION IN INDIA 

 

PRODUCT 

INDICATION

Pre-Clinical/Phase I

Phase II/III

Pre-Market

In Market

Rx Drug

GastrafateRx   

Functional Dyspepsia

xx

xx

xx

xx  2005

Rx Drug

GastrafateIB

IBS, All 3 Forms

xx

xx

xx

xx  2006

Rx Drug

GastrafateLoAl

GERD

xx

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rx Device

OraEsophate

Pediatric/Adult Mucosal Lesions

xx

xx

 

 xx Late 2007

Rx Device

Dermafate Wound

Pediatric/Adult Epidermal Wounds

xx

xx

xx

xx  Late 2007

Rx Device

Dermafate Burn

Pediatric/Adult Epidermal Burns

XX

xx

xx

 

 

 

 

 

 

 

 

OTC

Gastralox Ultra

Heartburn Severe

xx

xx

xx

xx Late 2007

OTC

Caralox

Heartburn

xx

xx

xx

xx Late 2007

OTC

Regalur IB

Irregularity of Irritable Bowel

xx

xx

xx

 

OTC

TriFiberlan

Fiber Irregularity

xx

xx

xx

 

 

New Chemical Entity Research and Development Program (2006-2009)

Program

Chemical Entity

Patented Uniqueness

3rd Generation Sucralfate

Aluminum Free Sucralfate

Growth Factor Activation

Para-Sucralfate Formulations

Sucralfate Type Entities

Growth Factor Activation

Adjuvant  Program for IBD

Adjuvant Enhanced Products

Mucosal and Submucosal Anti-inflammatory Action